GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples.
The purpose of this study was to evaluate the GenoType MTBDRplus assay (Hain Lifescience GmbH, Nehren, Germany) for its ability to detect resistance to rifampin (RIF) and isoniazid (INH) in Mycobacterium tuberculosis clinical strains and directly in clinical samples. A total of 62 clinical strains characterized with the Bactec 460TB system were included. For the INH-resistant strains, the MIC was measured and sequencing was performed. Sixty-five clinical samples from 28 patients (39 smear-positive samples and 26 smear-negative samples) were also tested directly. The corresponding isolates of the clinical specimens were studied with the Bactec 460TB system. The overall rates of concordance of the MTBDRplus assay and the Bactec 460TB system for the detection of RIF and INH susceptibility in clinical strains were 98.3% (61/62) and 79% (49/62), respectively. The rate of concordance between the Bactec 460TB system and the MTBDRplus test for the detection of INH resistance in the group of 27 strains with low-level resistance was 62.9% (17/27), and that for the detection of INH resistance in the group of 21 strains with high-level resistance was 85.71% (18/21). Valid test results were obtained for 78.45% (51/65) of the clinical samples tested. The rates of concordance between both assays for the detection of drug resistance in these samples were 98% (50/51) for RIF and 96.2% (49/51) for INH. Taking into account only one sample per patient, the overall rate of concordance between both tests was 92.85% (26/28). The GenoType MTBDRplus assay is easy to perform and is a useful tool for the management of tuberculosis, as it allows the detection of resistance to RIF and INH in M. tuberculosis strains and also in clinical samples.
Lacoma
A
A
Servei de Microbiologia, Fundació Institut en Ciències de la Salut Germans Trias i Pujol, Carretera del Canyet s/n, Badalona 08916, Barcelona, Spain. jadomb@gmail.com
Garcia-Sierra
N
N
Prat
C
C
Ruiz-Manzano
J
J
Haba
L
L
Rosés
S
S
Maldonado
J
J
Domínguez
J
J
D000995:Antitubercular Agents / Q000494:pharmacology*; D001431:Bacteriological Techniques / Q000379:methods*; D004269:DNA, Bacterial / Q000235:genetics*; D004351:Drug Resistance; D005838:Genotype; D005858:Germany; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests / Q000379:methods; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D011237:Predictive Value of Tests; D012293:Rifampin / Q000494:pharmacology*; D012680:Sensitivity and Specificity; D017422:Sequence Analysis, DNA; D014376:Tuberculosis / Q000382:microbiology
D000995:Antitubercular Agents; D004269:DNA, Bacterial; D007538:Isoniazid; D012293:Rifampin
Microb Drug Resist. 2005 Summer;11(2):107-14
15910223
J Clin Microbiol. 2001 Jan;39(1):107-10
11136757
J Infect Dis. 2000 Dec;182(6):1788-90
11069256
Eur J Clin Microbiol Infect Dis. 2007 Jan;26(1):51-5
17180347
J Clin Microbiol. 2006 Jan;44(1):201-5
16390970
Science. 1993 May 7;260(5109):819-22
8484123
Br Med Bull. 1984 Jan;40(1):84-90
6442876
Eur J Clin Microbiol Infect Dis. 1998 Mar;17(3):189-92
9665301
J Clin Microbiol. 2007 Aug;45(8):2635-40
17537937
J Clin Microbiol. 2006 Jul;44(7):2605-8
16825393
Am Rev Respir Dis. 1988 May;137(5):1217-22
3195815
Antimicrob Agents Chemother. 2003 Apr;47(4):1241-50
12654653
J Clin Microbiol. 2006 Feb;44(2):350-2
16455882
Tuber Lung Dis. 1998;79(1):3-29
10645439
J Clin Microbiol. 2008 Jan;46(1):393-4
17977988
J Antimicrob Chemother. 2005 Jun;55(6):860-5
15879493
Lancet. 1993 Mar 13;341(8846):647-50
8095569
Clin Microbiol Infect. 2007 Dec;13(12):1144-56
17727670
J Clin Microbiol. 2006 Jul;44(7):2338-42
16825346
Emerg Infect Dis. 1998 Apr-Jun;4(2):195-209
9621190
Clin Microbiol Infect. 2005 Feb;11(2):122-30
15679486
Respir Res. 2001;2(3):164-8
11686881
J Clin Microbiol. 2006 Oct;44(10):3659-64
17021094
J Clin Microbiol. 2003 Jun;41(6):2647-9
12791894
J Clin Microbiol. 2005 Aug;43(8):3699-703
16081898
J Clin Microbiol. 2006 Jul;44(7):2485-91
16825369